Strategic Positioning in High-Growth Efficacious Skincare Sector 

 Strengthening Business Synergies and Broadening Revenue Streams 

(Hong Kong, 15 May, 2026) – Eternal Beauty Holdings Limited (“Eternal Beauty” or the “Group”; stock code: 6883.HK), a leading player in China’s perfume industry, is pleased to announce that its wholly owned subsidiary, Eternal (China) International Trading Co., Ltd., has entered into a capital increase subscription agreement and a shareholders’ agreement to subscribe for the newly registered capital of RMB 795,037 in 杭州白晝與夢生物科技有限公司 (Brightday and Dream Biotechnology Co., Ltd.) (“Brightday and Dream”) for a total consideration of RMB 97,500,000. Upon completion of the capital increase, Eternal Beauty will acquire a 15% equity interest in Brightday and Dream, and the relevant authorities of the People’s Republic of China are currently processing the business registration changes.

Brightday and Dream is principally engaged in the operation of the aromatherapy efficacy skincare, personal care, and fragrance brand “AromeManpo”, as well as in the research, development, and sales of products under the brand. The brand has established a skincare system integrating “aromatherapy plants + efficacious ingredients + biotechnology compounding”. Centred on natural aromatherapy plants, it conducts in-depth scientific research to craft exclusive botanical raw materials and compounds with high-performance efficacious ingredients to deliver key effects, thereby improving skin conditions and providing emotional healing. 

Ms. Lam King, Executive Director and Chief Executive Officer of the Group, stated: “This strategic investment is a key initiative for us to optimise capital allocation and position ourselves in high-growth segments. This equity investment will enable Eternal Beauty to capture structural growth opportunities in the efficacious skincare and personal care industry, broaden and deepen our business presence in this high-growth sector, while enriching our brand portfolio, and optimising the Group’s overall business structure.”

In recent years, consumer demand for natural, therapeutic, and professional efficacy skincare and personal care products has continued to grow, with the relevant market scale expanding steadily. Leveraging AromeManpo’s clear and differentiated positioning, unique aesthetic system, dedicated scientific research capabilities, and keen insights into consumer needs and market trends, it has established a significant competitive advantage in the market and favourable growth potential within its niche segment.

Ms. Lam continued: “Leveraging the Group’s well-established omni sales channel network, extensive experience in operating premium brands, and substantial high-net-worth customers, we look forward to generating strong synergies with Brightday and Dream in areas including channel resource sharing, joint brand expansion and in-depth market penetration. We will also fully support the further expansion of AromeManpo across omni-channels in the Greater China market and even international markets. We believe that the brand’s development prospects will deliver desirable and sustainable investment returns to the Company.”